Biomarin Pharmaceutical (BMRN) Com Stk USD0.001
0.64%- This stock can be held in a
Stocks and Shares ISASell:$82.16
Buy:$82.18
Change:
$8.61 (9.44%)
$8.61 (9.44%)Market closed | Prices delayed by at least 15 minutes
Sell:$82.16
Buy:$82.18
Change:$8.61 (9.44%)
$8.61 (9.44%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 April 2024 | Jean Jacques BienaimeChairman/CEO | Sell Option/Award related | 20,000 | $91.26 | $1,825,200.00 | 474,994 |
| 11 April 2024 | Jean Jacques BienaimeChairman/CEO | Sell Option/Award related | 20,000 | $90.99 | $1,819,800.00 | 474,994 |
| 10 April 2024 | Erin BurkhartChief Accounting Officer | Sell Regular sell transaction (market) | 2,286 | $90.00 | $205,740.00 | 16,156 |
| 28 March 2024 | George Eric DavisChief Legal/Compliance Officer | Sell Regular sell transaction (market) | 24,602 | $88.34 | $2,173,340.68 | 55,856 |
| 18 March 2024 | Dennis Joseph SlamonDirector | Sell Tax related | 9,510 | $83.81 | $797,033.10 | 31,299 |
| 18 March 2024 | Erin BurkhartChief Accounting Officer | Sell Tax related | 372 | $83.87 | $31,199.64 | 18,442 |
| 15 March 2024 | Jean Jacques BienaimeChairman/CEO | Sell Tax related | 85,209 | $83.87 | $7,146,478.83 | 474,994 |
| 15 March 2024 | Henry J. (Hank) FuchsOther President | Sell Tax related | 33,485 | $83.87 | $2,808,386.95 | 196,872 |
| 15 March 2024 | George Eric DavisChief Legal/Compliance Officer | Sell Tax related | 21,699 | $83.87 | $1,819,895.13 | 80,458 |
| 15 March 2024 | Charles Greg GuyerCTO | Sell Tax related | 20,424 | $83.87 | $1,712,960.88 | 78,327 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 March 2024 | Jean Jacques BienaimeChairman/CEO | Sell Tax related | 85,209 | $83.87 | $7,146,478.83 | 474,994 |
| 12 May 2023 | Jean Jacques BienaimeChairman/CEO | Sell Tax related | 33,644 | $93.93 | $3,160,180.92 | 432,732 |
| 5 March 2024 | Henry J. (Hank) FuchsOther President | Sell Regular sell transaction (market) | 35,341 | $85.18 | $3,010,395.86 | 212,117 |
| 15 March 2024 | Henry J. (Hank) FuchsOther President | Sell Tax related | 33,485 | $83.87 | $2,808,386.95 | 196,872 |
| 11 May 2023 | Jean Jacques BienaimeChairman/CEO | Sell Option/Award related | 24,439 | $94.55 | $2,310,707.45 | 431,774 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.